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Polycyclic aromatic hydrocarbons (PAHs) cover a wide range of
structurally related compounds which differ greatly in their car-
cinogenic potency. PAH exposure usually occurs through mixtures
rather than individual compounds.Therefore,we assessedwhether
the effects of binary PAH mixtures on gene expression, DNA ad-
duct formation, apoptosis and cell cycle are additive compared
with the effects of the individual compounds in human hepatoma
cells (HepG2). Equimolar and equitoxic mixtures of benzo[a]
pyrene (B[a]P) with either dibenzo[a,l]pyrene (DB[a,l]P), diben-
zo[a,h]anthracene (DB[a,h]A), benzo[b]fluoranthene (B[b]F), flu-
oranthene (FA) or 1-methylphenanthrene (1-MPA) were studied.
DB[a,l]P, B[a]P, DB[a,h]A and B[b]F dose-dependently increased
apoptosis and blocked cells cycle in S-phase. PAH mixtures
showed an additive effect on apoptosis and on cell cycle blockage.
DNA adduct formation in mixtures was higher than expected
based on the individual compounds, indicating a synergistic effect
of PAH mixtures. Equimolar mixtures of B[a]P and DB[a,l]P (0.1,
0.3 and 1.0 mM) were assessed for their effects on gene expression.
Only at 1.0 mM, the mixture showed antagonism. All five com-
pounds were also tested as a binary mixture with B[a]P in equi-
toxic concentrations. The combinations of B[a]P with B[b]F,
DB[a,h]A or FA showed additivity, whereas B[a]P with DB[a,l]P
or 1-MPA showed antagonism. Many individual genes showed
additivity in mixtures, but some genes showed mostly antagonism
or synergism. Our results show that the effects of binary mixtures
of PAHs on gene expression are generally additive or slightly
antagonistic, suggesting no effect or decreased carcinogenic po-
tency, whereas the effects on DNA adduct formation show syner-
gism, which rather indicates increased carcinogenic potency.
Introduction
Polycyclic aromatic hydrocarbons (PAHs) are organic compounds
present in the air after incomplete combustion of organic fuels. PAHs
cover a wide range of structurally related compounds with a diverse
range in carcinogenic and mutagenic potency.
Many PAHs bind to the Aryl hydrocarbon (Ah) receptor, which
translocates to the nucleus and induces the expression of several
genes, among which several genes for cytochrome P450 enzymes
(e.g. CYP1A1, CYP1A2 and CYP1B1) (1). These enzymes are capable
of metabolizing PAHs to their reactive intermediates (2). PAHs vary in
their affinity for the Ah-receptor and thereby the induction of cyto-
chrome P450 enzymes will vary accordingly (3). Many PAHs are able
to bind to DNA after metabolic activation and thereby form DNA
adducts. When these DNA adducts are not properly removed or re-
paired, mutations can occur and thereby induction of cancer develop-
ment (4). Although different PAH adducts are repaired with different
accuracy and at different rate, DNA adduct formation has been shown
to correlate with mutagenic potency of PAHs (4,5). DNA adducts can
also affect the p53 pathway, which may lead to changes in biological
processes (such as cell cycle arrest or apoptosis) (6). We have shown
previously that PAHs can induce compound-specific gene expression
profiles in HepG2 cells and that these profiles can be related to the
carcinogenic potency of the PAH (7).
PAH exposure usually occurs through mixtures, and the various
compounds may modulate the effect of other compounds. PAH inter-
actions can lead to an addition of the effect of both PAHs (additivity)
or to a higher effect than expected based on additivity (synergism), or
PAHs may repress the effects of the other PAH (antagonism) (8,9).
Either synergism or antagonism can be expected in PAH mixtures,
which is further explained by two hypotheses.
The first hypothesis suggests synergism, which occurs when the
metabolism of a compound is influenced by another (10). This may
occur, for example, when cells are exposed to benzo[a]pyrene
(B[a]P)—an inducer of the CYP1A1 gene expression—in combina-
tion with a PAH which is not able to induce CYP1A1. The non-
CYP1A1 inducing compound may be metabolically activated at in-
creased rate by the B[a]P-induced CYP1A1 levels, thereby leading to
enhanced DNA adduct formation and consequently enhanced muta-
genesis and carcinogenesis.
The second hypothesis suggests antagonism. It has been shown that
the expression of the CYP1A1 gene and protein is decreased in HepG2
cells after exposure to B[a]P and 1-nitropyrene compared with B[a]P
alone (11). This was also found for mixtures of B[a]P with fluoran-
thene (FA) in the EROD assay (12). Theoretically, this would lead to
decreased metabolism of B[a]P and thereby less DNA adduct forma-
tion and reduced toxic and carcinogenic potency of B[a]P.
This study aims to gain knowledge on interactive effects in binary
PAH mixtures on gene expression profiles in human cells. To our
knowledge, we are the first to study the effects of binary PAH mix-
tures on gene expression profiles obtained by microarray technology,
combined with apoptosis, cell cycle and DNA adduct formation.
Since liver is an important organ in metabolism of xenobiotic
compounds, and the human hepatoma cell line HepG2 is competent
in PAH metabolism and was shown to give PAH-specific gene ex-
pression profiles, we used this cell line to study interaction between
PAHs. Six PAHs were selected based on their environmental
occurrence and carcinogenic potency (13,14), namely in order of
occurrence benzo[b]fluoranthene (B[b]F)  fluoranthene (FA) 
1-methylphenanthrene (1-MPA) . B[a]P . dibenzo[a,h]anthracene
(DB[a,h]A) . dibenzo[a,l]pyrene (DB[a,l]P). Carcinogenic potency
differs greatly between these PAHs and can be arranged from high to
low: DB[a,l]P . DB[a,h]A . B[a]P . Bb]F . FA  1-MPA. B[a]P,
B[b]F and DB[a,h]A induced the CYP1A1 expression, whereas
DB[a,l]P mildly induced CYP1A1 and FA and 1-MPA did not affect
the expression of CYP1A1 (7). We assessed the effects of equimolar
mixtures of B[a]P and DB[a,l]P in the low toxic range as well as the
effects of equitoxic mixtures of each PAH with B[a]P. We measured
cell cycle distribution and apoptosis by FACS analysis, DNA adduct
formation by 32P-post-labelling and gene expression changes by mi-
croarray analysis using a PHASE-I array containing 600 toxicologi-
cally relevant genes. All data were used to study the effects of
a mixture of PAH in relation to the effects of the individual com-
pounds using an additive model to estimate the mixture effect.
Materials and methods
Chemicals
B[a]P (purity 97%, CAS no. 50-32-8), B[b]F (purity 98%, CAS no. 205-99-2),
FA (purity 99%, CAS no. 206-44-0), DB[a,h]A (purity 97%, CAS no. 53-70-3)
Abbreviations: B[a]P, benzo[a]pyrene; B[b]F, benzo[b]fluoranthene; DB[a,-
h]A, dibenzo[a,h]anthracene; DB[a,l]P, dibenzo[a,l]pyrene; DMSO, dimethyl
sulfoxide; FA, fluoranthene; PAH, polycyclic aromatic hydrocarbon; PCR,
polymerase chain reaction; RT, real-time; 1-MPA, 1-methylphenanthrene.
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and DB[a,l]P (purity 99,6%, CAS no. 191-30-0) were obtained from Sigma-
Aldich (Zwijndrecht, The Netherlands). 1-MPA (purity 99%, CAS no. 832-69-9)
was obtained from LGC Promchem (Teddington, UK). All chemicals were
dissolved in dimethyl sulfoxide (DMSO).
Cell culture and treatment
HepG2 cells were cultured in Minimal Essential Medium supplemented with
1% non-essential amino acids, 1% sodium pyruvate, 2% penicillin/streptomy-
cin and 10% fetal bovine serum (all from Gibco BRL, Breda, The Netherlands)
in T25 culture flasks at 37C and 5% CO2. One day before treatment, cell
cultures at 70–80% confluency were harvested and cells were undilutedly di-
vided among six-well plates (for flow cytometry, 600 000 cells) or new culture
flasks (for gene expression and DNA adduct analysis, 2.5  106 cells), in
order to obtain a homogeneous cell population for each treatment. The next
day, the medium was replaced with fresh medium containing 1 nM to 30 lM of
a PAH, an equimolar or equitoxic mixture of two PAHs or a vehicle control
(DMSO, 0.1%). The cells were exposed for 24 h, and thereafter either cells
were fixed with 2 ml cold methanol and stored at 20C (six-well plates, for
FACS analysis) or media was removed from the culture flasks (90% conflu-
ent) and 1 ml Trizol (Gibco BRL) was immediately added to the cells (for RNA
and DNA isolation). Two independent experiments were conducted.
Flow cytometric analysis for cell cycle and apoptosis
For flow cytometry, we used the primary antibody M30 CytoDeath (Roche,
Penzberg, Germany) and the producers’ manual. Wash buffer was replaced with
phosphate-buffered saline containing 1 mg/ml bovine serum albumin. The
secondary antibody, fluorescein isothiocyanate-conjugated anti-mouse Ig,
was obtained from DakoCytomation (Glostrup, Denmark), which was incu-
bated in the dark overnight at 4C. After washing, the cells were re-suspended
in 0.5 ml phosphate-buffered saline containing 20 lg/ml propidium iodide and
incubated 15 min at room temperature prior to flow cytometric analysis.
A FACSort (Becton Dickinson, Sunnyvale, CA) equipped with an Argon ion
laser and a diode laser was used for flow cytometric analysis. An excitation
wavelength of 488 nm and emission filters of 515–545 nm band pass and 600
nm low pass were used. For each sample 10 000 cells were analyzed. Fluo-
rescein isothiocyanate signals were recorded as logarithmic amplified data and
the propidium iodide signals as linear amplified data. Electronic compensation
was used to eliminate any bleed trough of fluorescence. Data analysis was done
using CellQuest software (version 3.1, Becton Dickinson, San Jose, CA). Data
were gated on pulse-processed propidium iodide signals to exclude doublets
and larger aggregates from the analysis.
M30 CytoDeath positive (apoptotic) and negative (non-apoptotic) signals
were sorted in the gated population and displayed as percentage of total cells
with WinMDI 2.8 (http://facs.scripps.edu/software.html, 15 May 2006). Cell
cycle was analyzed on the gated population of single using ModFit LT for Mac
(version 2.0). Cells in the G0–1, S or G2-M phase were expressed as a percentage
of the total number of cells.
Expected apoptosis levels were calculated by adding the total percentage of
apoptosis of both constituents and subtracting the basal percentage of apoptosis
found for the control sample.
DNA adduct formation
As DNA recoveries from cells exposed to equimolar concentrations of PAHs
were limited, we only measured DNA adduct formation in cells exposed to
equitoxic concentrations of PAHs.
After removal of the aqueous phase during RNA isolation using Trizol (see
RNA isolation and quality control), the remaining phases were used for DNA
isolation according to manufacturer’s protocol. DNA adduct levels were de-
termined according to the procedure originally described by Reddy et al. (15)
with modifications described by Godschalk et al. (16). By including samples
with known DNA adduct levels (1 adduct per 106, 107 or 108 nucleotides),
DNA adduct levels were quantified (detection limit 1 adduct 108 nucleotides).
Adduct spots on the chromatograms were located and quantified using a phos-
phor imager (FLA-3000, Fuji, Paris, France) and AIDA/2D densometry software.
Expected DNA adduct levels were calculated by adding the total DNA
adduct levels of both constituents and subtracting the background DNA adduct
level found for the control sample. The limited number of analysis did not
allow statistical analysis.
RNA isolation and quality control
RNA was isolated from the Trizol solutions according to the producer’s manual
and purified with the RNeasy mini kit (Qiagen Westburg bv., Leusden, The
Netherlands). RNA quantity was measured on a spectrophotometer and
quality was determined on a BioAnalyzer (Agilent Technologies, Breda,
The Netherlands). Only RNA samples which showed clear 18S and 28S peaks
and with a RNA integrity number level .8 were used for labeling and hy-
bridization.
Gene expression analysis
cDNA synthesis RNA (10 lg per sample) was reverse transcribed into cDNA
with amino allyl-labelled deoxyuridine triphosphate (Sigma-Aldrich, St Louis,
MO) and subsequently labelled with one of the four dyes, namely Cy3, Cy5,
Alexa 488 and Alexa 594. Four instead of two dyes were applied, in order to
reduce the variation (four related samples are on one array instead of two) and
the number of arrays [as described by Staal et al. (17)].
Microarray hybridizations Targets were hybridized on the Human-600 Micro-
array (PHASE-1 Molecular Toxicology, Santa Fe, NM), containing 597 se-
quence-verified cDNA clones from human genes, representing a number of
toxicologically relevant, as well as control, genes, each printed in quadrupli-
cate. Hybridization and washing was done according to the producers’ manual
as described previously (17). Hybridization of the equimolar experiment was
designed such that all treatments of the same concentration were hybridized on
a single array and the dyes were swapped for the technical duplicate. The
hybridization design for the equitoxic experiment is shown in supplementary
Table 1 (available at Carcinogenesis Online).
Microarray data analysis and data mining The microarray slides were
scanned on a ScanArrayExpress (Perkin Elmer life sciences, Boston, MA).
All four channels were scanned at 100% laser power and adjusted photo
multiplier tube gain, such that the signal of the highest fluorescent spots is just
below the maximum measurable level. The images (10 l resolution; 16 bit tiff)
were processed with ImaGene 5.5 software (Biodiscovery, Los Angeles, CA)
to quantify spot signals. Abnormal spots were manually or automatically
flagged and not included in the data analysis.
Data from ImaGene were transported to GeneSight software version 4.1.6
(Biodiscovery) for transformations, normalizations and analyses. For each
spot, background mean was subtracted from signal means; flagged spots and
spots with a net expression level ,20 were omitted. Data were log base 2
transformed and expression difference between exposed and control were cal-
culated. Data normalization was done by LOWESS. Data of replicate spots
were combined while omitting outliers (.2 SDs). Samples from each biolog-
ical replicate were hybridized twice, thereby providing four hybridizations per
PAH concentration (two technical replicates for each biological replicate).
Only for B[a]P-exposed cells from the equitoxic experiment, eight hybridiza-
tions were available (four technical and two biological). Significantly modu-
lated genes were found by the confidence analysis tool in GeneSight, with
a minimal up-regulation or down-regulation of 0.5 (after 2log transformation)
and a confidence limit of 99%. To obtain equal statistical power for B[a]P-
exposed cells from the equitoxic experiment, the samples were split into two
groups (each containing two biological and two technical replicates) for the
analysis. The union of the modulated genes was assumed to be affected by the
treatment.
Real-time polymerase chain reaction
Quantitative real-time polymerase chain reaction (RT-PCR) was performed to
quantitate messenger RNA levels of a selection of genes in order to verify
expression changes from the microarray experiments. Reverse transcription
reaction was performed using 1 lg of total RNA using iScript cDNA Synthesis
Kit (Bio-Rad Laboratories, Hercules, CA). Subsequently, RT-PCR reactions
were performed using iQTM SYBR Green Supermix, containing iTaq DNA
Polymerase, deoxynucleoside triphosphates and SYBR Green I (Bio-Rad Lab-
oratories). All PCR reactions were performed in duplicate. b-actin messenger
RNA was used as reference in order to normalize expression levels and to
quantitate changes in gene expressions between the control and treated sam-
ples. The RT-PCR was run on the MyiQ Single-Color Real-Time PCR De-
tection System (Bio-Rad Laboratories): 3 min at 95C, 40 cycles of 95C for
15 s and 60C for 45 s. The following forward and reverse primers were used
(OPERON, 5#-3# sequences): CYP1A1 TCCTGGAGACCTTCCGACACT
(forward) and CTTTCAAACTTGTGTCTCTTGTTGTG (reverse), GADD45A
CGACCTGCAGTTTGCAATATGA (forward) and CCCCCACCTTATCCAT-
CCTT (reverse), APOC3 GAAAGACTACTGGAGCACCGTTAAG (forward)
and CACGGCTGAAGTTGGTCTGA (reverse), HIF1A TTTACCATGCCC-
CAGATTCAG (forward) and GGACTATTAGGCTCAGGTGAACTTTG
(reverse) and b-actin CCTGGCACCCAGCACAAT (forward) and
GCCGATCCACACGGAGTACT (reverse). Dissociation curve analysis was
performed and ‘no template controls’ were analyzed to check for non-specific
products in the reaction. For each sample, the quantity was derived from
Ct 5 Ct(target gene)Ct(b-actin reference). These values were log 2 trans-
formed, and the difference of each test relative to their concomitant vehicle
control sample was calculated (18).
Assessing additivity for gene expression modulation
Assuming additivity of both compounds in a mixture, the expected effects for
a mixture can be calculated. Comparing the observed modulations with the
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expected may provide information on whether the effects caused by mixtures
are additive, synergistic or antagonistic.
To calculate the expected gene expression modulation by a mixture of two
compounds based on the modulations of the individual compounds, only genes
were included which were significantly modulated by either of the individual
compounds or the mixture and which had the same direction of modulation (up
or down). Genes of which the expression difference (log transformed) was
between 0.1 and 0.1 were assumed to be similarly regulated as the other
compound of the mixture.
For up-regulated genes, starting with 2log transformed expression ratios of
the individual PAHs, the next formulae, were used to calculate the expected
2log transformed expression ratio for a gene in the mixture:
22logðPAH=CÞ 5 ðPAH=CÞ:
In which PAH is the expression of a gene following treatment with a PAH and
C is the expression of a gene following control treatment (DMSO). In this step,




5 ðB½aP=CÞ þ ðPAH=CÞ  1:
The expected effect of the mixture B[a]P and a PAH equals the sum of the
effect of B[a]P and of the other PAH minus the basal gene expression level of 1.
The expected 2log transformed expression ratio for a gene in a mixture:
5 2logððB½aP=CÞþðPAH=CÞ  1Þ:
For down-regulated genes, starting with 2log transformed expression ratios of
the individual PAHs, the following formulae were used to calculate the ex-
pected 2log transformed expression ratio for a gene in a mixture:
1=22logðPAH=CÞ 5 ðC=PAHÞ:
In which PAH is the expression of a gene following treatment with a PAH
and C is the expression of a gene following control treatment (DMSO). In this
step, the 2log transformed expression ratios are transformed back into non-
logarithmic values, followed by a calculation of its inverse (hereby the effects
are transformed into up-regulations). Then the same procedure is followed as
above (from step 2 onwards), finalized with inversing back the value before log
transformation.
Finally, the observed gene expression values (y-axis) were plotted versus the
expected values (x-axis). Linear regression analysis and Pearson correlation
coefficients were calculated using SPSS 12.0.1 for windows (SPSS, Chicago,
IL). Additivity was assumed when regression analysis for the observed and
expected data did not show a deviation from y 5 x (confidence interval of
2 SD). If it did deviate from y 5 x, synergism is shown by a slope .1 and
antagonism by a slope ,1.
To assess whether the expression of single genes showed additivity, the
formulae as described above were used. Expected gene expression levels
showed additive response if they fall within the confidence interval (1 SD)
of the observed gene expression modulation. If not, the gene was classified as
being higher or lower expressed than expected for that mixture.
Results
Equimolar concentrations
Apoptosis and cell cycle changes Flow cytometric analysis of cells
exposed to B[a]P, DB[a,l]P or an equimolar mixture of both com-
pounds showed dose-dependent induction of apoptosis (supplemen-
tary Figure 1 is available at Carcinogenesis Online). DB[a,l]P and the
mixture increased apoptosis levels from 0.1 lM and higher, whereas
for B[a]P this was at 3 lM and higher.
An increase of cells in S-phase was seen after 0.01 lM with a sub-
sequent decrease from 0.1 lM for all treatments (Figure 1). For B[a]P,
an increased percentage of cells in S-phase was observed from 0.3 lM
and higher, and DB[a,l]P and the mixture showed increased S-phase
from 0.01 to 0.003 lM and higher, respectively.
Based on these data, concentrations of 0.1, 0.3 and 1.0 lM were
used for gene expression analysis.
Gene expression modulation Microarray analysis showed that a total
number of 127 genes were affected by one or more treatments. For
B[a]P 2, 5 and 6 genes were modulated by, respectively, 0.1, 0.3 and
1.0 lM exposure, for DB[a,l]P 7, 29 and 72 genes were affected and
for the mixture 6, 49 and 77 genes. Many, but not all, genes affected
by B[a]P or DB[a,l]P were also affected by the mixture, although the
mixture also affected genes which were not modulated by one of the
constituents. Names, abbreviations, GenBank accession numbers and
gene expression differences of the modulated genes can be found in
the supplementary data file (Table 2 is available at Carcinogenesis
Online).
Principal component analysis, Figure 2, showed that gene expres-
sion profiles induced by B[a]P are similar for all concentrations and
different from either the mixture or DB[a,l]P. The gene expression
profiles of DB[a,l]P and the mixture treatments were closely related
between each concentration of treatment, but the resemblance be-
tween gene expression profiles induced by DB[a,l]P and the mixture
decreased with increasing concentration of treatment. This suggests
a contribution of B[a]P to the mixture at the higher concentrations.
Assessing the additivity of effects induced by the mixture By using the
gene expression profiles of B[a]P and DB[a,l]P, it was possible to
calculate the expected effect of the mixture for the significantly mod-
ulated genes. Expected gene expression levels were plotted against
observed expression levels for all concentrations (Figure 3). For the
0.3 and 1.0 lM treatments, the correlation coefficient was significant
(P , 0.05). At 1.0 lM, we found a significant deviation from the line
Fig. 1. Percentage of HepG2 cells in the S-phase of cell cycle after exposure
to B[a]P, DB[a,l]P or their equimolar mixture for 24 h. Means of duplicate
experiments and their standard deviation are indicated.
Fig. 2. Principal component analysis of gene expression differences in
HepG2 cells after exposure for 24 h to B[a]P, DB[a,l]P or their equimolar
mixture with the 127 genes differentially expressed by either of the
treatments. Each circle contains the same concentration of treatment with
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y 5 x in these regression models, where antagonism is shown (slope
, 1). The mixture effects at 0.1 and 0.3 lM are unclear due to the
small contribution of B[a]P to the mixture.
Also, individual genes show interactive effect after exposure to the
mixture. The expression of 12 genes consistently showed additivity of
the gene expression of the mixture. These genes were ACTGP3,
ATF3, CDH2, CDKN1A, CHK, CYP2C19, GADD45A, HAMP,
MMP3, MT2A, SLC6A9 and an unknown gene with GenBank acces-
sion number XM_010682. No genes showed consistent antagonistic
or synergistic responses.
Equitoxic concentrations
Apoptosis and cell cycle changes Apoptosis and cell cycle disturban-
ces were measured for each of the six PAHs in concentrations ranging
from 0.01 to 30 lM. All PAHs increased apoptosis levels in HepG2
cells, except FA and 1-MPA (supplementary Figure 2A, available at
Carcinogenesis Online). B[a]P, DB[a,l]P, B[b]F and DB[a,h]A in-
creased apoptosis levels from 3.0, 0.1, 10.0 and 1.0 lM and higher,
respectively.
Many PAHs also increased the number of cells in S-phase; only FA
and 1-MPA did not affect cell cycle (supplementary Figure 2B, avail-
able at Carcinogenesis Online). B[a]P, DB[a,l]P, B[b]F and DB[a,h]A
disturbed cell cycle from 0.3, 0.01, 0.1 and 0.03 lM and higher, re-
spectively.
Concentrations to study the effects of equitoxic concentrations
were selected based on these apoptosis and cell cycle data. Each
PAH affected both parameters at similar concentrations, only B[b]F
disturbed cell cycle at much lower concentrations than apoptosis in-
duction. As FA and 1-MPA did not change either apoptosis or in cell
cycle, the highest concentration (30 lM) was used to study the effects
of mixtures with B[a]P. The concentrations selected for B[a]P,
DB[a,l]P, B[b]F and DB[a,h]A were, respectively, 3.0, 0.1, 3.0 and
1.0 lM.
None of the apoptosis levels induced by the mixture of a PAH with
B[a]P differed significantly from the expected effect (Figure 4). The
percentage of cells in S-phase of cell cycle after treatment with a mix-
ture resembled mostly that after B[a]P treatment (no significant de-
viation; Figure 4).
DNA adduct formation DNA adduct formation as measured by 32P-
post-labelling in the HepG2 cells exposed to the equitoxic concen-
trations of PAHs is shown in Figure 5. DNA adduct formation for
equitoxic concentrations was B[a]P . B[b]F . DB[a,l]P  DB[a,h]A
. FA  1-MPA. Interestingly, the mixtures of B[a]P with FA or 1-
MPA induced the highest DNA adduct levels, whereas FA and 1-MPA
itself did not induce DNA adducts. For these treatments, the B[a]P
adduct spots were increased and no other adducts were found. All
mixtures showed higher DNA adduct levels than expected, which
indicates a synergistic effect on DNA adduct formation.
Fig. 3. Expected (based on additivity) versus observed gene expression of
the equimolar mixture of B[a]P and DB[a,l]P for the concentrations 0.1, 0.3
and 1.0 lM in a, b and c, respectively. Correlation coefficients (R2) and the
line equation are indicated in the graph.
Fig. 4. Apoptosis in HepG2 cells (a) or percentage of HepG2 cells in the
S-phase of cell cycle (b) after exposure to B[a]P, DB[a,l]P, DB[a,h]A, B[b]F,
FA or 1-MPA or a mixture of each PAH with B[a]P for 24 h expressed as
a percentage of total cells. Means of duplicate experiments and their standard
deviation are indicated.
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Gene expression modulation In total, 54 genes were modulated by
one or more treatments, varying from one gene for the 1-MPA and FA
treatments to 37 genes by the treatment with a mixture of B[a]P/
B[b]F. The numbers of modulated genes for each treatment and the
overlap between treatments shows that most genes modulated by
a single compound were also modulated by their mixture with
B[a]P (supplementary Figure 3 is available at Carcinogenesis Online).
Names, abbreviations, GenBank accession numbers and gene expres-
sion differences of the modulated genes can be found in the supple-
mentary data (Table 3 is available at Carcinogenesis Online).
Assessing the additivity of effects induced by the mixture Expected
gene expression profiles of the mixture were calculated based on the
gene expression profiles of its individual compounds and plotted
against the observed expression levels (Figure 6). All correlation co-
efficients were significant. Regression analysis showed that only mix-
tures with DB[a,l]P and 1-MPA deviate significantly from the line
y 5 x, and the observed values were smaller than expected (slope
,1), indicating an antagonistic effect. For mixtures of B[a]P with
either B[b]F, DB[a,h]A or FA this deviation was not observed, sug-
gesting an additive effect for these mixtures.
Comparing the observed and expected gene expression level for
single genes showed that for 14 genes the observed and expected
values did not differ of the gene expression of the mixture. Also,
we found a synergistic or antagonistic effect on gene expression for
12 out of 55 modulated genes (observed consistently higher or lower
than expected). Table I shows the interactive effects of each gene for
all mixtures. An overview of all interactive effects in equitoxic mix-
tures is shown in Table II.
Validation by RT-PCR Gene expression modulation and interactive
effects for four genes (CYP1A1, GADD45A, APOC3 and HIF1A) was
validated by quantitative RT-PCR. The direction of modulation was
similar for all genes assessed and each of the treatments (single com-
pounds and mixtures), although the extent of modulation was slightly
higher for RT-PCR compared with microarray analysis (supplemen-
tary Figure 4 is available at Carcinogenesis Online). For each gene
and mixture, the interactive effect is similar for microarray analysis
and RT-PCR, as shown in Figure 7. This indicates that the interactive
results obtained by microarray analysis are an accurate estimation of
the interactive effect of PAH mixtures on gene expression.
Discussion
This study focuses on the effects of binary mixtures of PAHs on cell
cycle, apoptosis, DNA adduct formation and gene expression modu-
lation. We compared the observed gene expression effects of equimo-
lar and equitoxic PAH mixtures with the expected data based on
additivity of its individual compounds in HepG2 cells. We aim to gain
insight into the effects of PAH mixtures and test possibility synergis-
tic, antagonistic or additive effects of a mixture. Mixtures were as-
sessed on their interactive effects based on an additive model.
Deviation from this model indicated either synergism or antagonism.
Cell cycle and apoptosis
The effect on cell cycle and apoptosis in HepG2 cells treated with
equimolar concentrations of B[a]P and DB[a,l]P was found to resem-
ble the effects of DB[a,l]P alone. B[a]P had little effect on apoptosis
and therefore did not contribute to the apoptosis of HepG2 cells
exposed to the B[a]P/DB[a,l]P mixture. B[a]P did block cells in
S-phase of cell cycle, although at higher concentrations than DB[a,l]P
and therefore the effect of B[a]P on cell cycle in the equimolar B[a]P/
DB[a,l]P mixture mainly represented the effects of DB[a,l]P.
Of all six PAHs tested, we found that DB[a,l]P and B[a]P are most
toxic to HepG2 cells in the concentration range tested. Effects on cell
cycle were shown by an increased number of cells in S-phase, which
has been observed in other studies as well (19).
Equitoxic mixtures of each PAH with B[a]P showed slightly in-
creased levels of apoptosis compared with the compounds individu-
ally. Only FA and DB[a,l]P showed some synergism. Interaction on
S-phase arrest did not occur. No comparable literature data were
available.
DNA adduct formation
DNA adduct formation in HepG2 cells after exposure to equitoxic
PAH concentrations showed that equally toxic concentrations (based
on apoptosis and cell cycle disturbances) did not induce the same level
of DNA adducts in HepG2 cells. This indicates that the cytotoxic
effects are not directly related to the total DNA adduct levels. Mix-
tures of two PAHs showed synergism on DNA adducts formation for
all mixtures. Possibly, PAH activation is enhanced in co-exposure of
PAHs leading to a higher level of DNA reactive metabolites. This
seems to be indicated by a synergistic effect on the expression of
CYP1A2 which we found for B[a]P/DB[a,h]A and B[a]P/DB[a,l]P.
Or, as Uno et al. (2) found increased levels of DNA adducts in
CYP1A1 knockout mice, which results in a reduced metabolism of
PAHs in mixtures, and may lead to higher DNA adduct levels. Also,
phase II enzymes involved in detoxifying PAH metabolites might be
saturated and thereby leading to increased levels of PAH metabolites.
Our findings were not supported by earlier studies, in which an
antagonistic effect of PAH mixtures on DNA adduct formation was
found in MCF7 cells (20), which may be due to the differences be-
tween breast tissue and actively metabolizing liver tissue or to the
more complex mixtures studied. The synergistic effect found on DNA
adduct formation seems to be strongest for FA and 1-MPA, which did
not induce DNA adducts individually, but which are neither inducers
of CYP450 activity. This might prove an important role of these low
carcinogenic compounds in co-carcinogenesis, though the mechanism
is currently not understood.
Gene expression modulation
For DB[a,l]P, FA and 1-MPA low numbers of genes were found to be
affected in the equitoxic experiment. As we used the highest dose of
30 lM for the latter two compounds, these compounds probably have
little effect on gene expression in HepG2 cells, as was shown pre-
viously (7). For DB[a,l]P, we used the 0.01 lM concentration since at
this dose it already showed increased apoptosis levels and marked cell
cycle changes. However, DB[a,l]P had a small effect on gene expres-
sion at this concentration.
Assessing the additivity of gene expression profiles for mixtures
As the effects in equimolar mixtures were dominated by the effects of
DB[a,l]P, we did not include those data in assessing the interactive effects
of PAH mixtures. However, the effects at the highest concentration,
Fig. 5. DNA adduct formation in HepG2 cells exposed to equitoxic
concentrations of PAHs for 24 h as measured by 32P-post-labelling. The
mean number of DNA adducts per 108 nucleotides and their standard
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at which both compounds contributed to the effects of the mixture,
shows antagonism, which agrees with the effects shown by this
mixture at equitoxic concentrations. However, only eight genes
were significantly modulated at the highest concentration of the
equimolar mixture and by the equitoxic mixture of B[a]P/DB[a,l]P.
Comparison of observed and expected gene expression levels
(Figure 6) showed that the interactive effects on gene expression
profiles differ between PAH mixtures. Mixtures of B[a]P with
B[b]F, FA and DB[a,h]A showed additive effects on gene expression,
whereas the mixtures of B[a]P with DB[a,l]P and with 1-MPA
showed antagonism.
Assessing additivity of differential expression for single genes
The expression of many genes showed additivity for many conditions
in either of the experiments. Some of these genes are involved in PAH
metabolism, like CYP1A1, and many others are related to tumorigen-
esis. Only one gene was found to show additivity at the equimolar as
well as the equitoxic concentrations, which was ATF3. Since only one
gene shows similar interaction in the equimolar and equitoxic mix-
tures, it shows that interactive effects are dependent on the concen-
trations selected.
Furthermore, 13 genes showed mostly synergism or antagonism in
the various mixtures (Table I). Many of these genes can be related to
DNA damage induces by PAH and the early onset of carcinogenesis.
These genes include XRCC1 and GADD45a, which are involved in
DNA damage repair (21,22), and MT2A which is involved in pro-
tection against oxidative stress (23). The expression of many of these
carcinogenesis-related genes is higher expressed than expected,
indicating a higher damaging effect of PAHs in mixtures than the
individual compounds suggest. This is in agreement with the levels
of DNA adducts we found after exposure to PAH mixtures. The ex-
pression of some other genes related to cell cycle or DNA damage
(CDKN1A and BAX) did not show interaction for more than one
mixture.
Fig. 6. Expected (based on additivity) (x-axis) versus observed (y-axis) gene expression of the equitoxic mixture of B[a]P and B[b]F (a), FA (b), DB[a,h]A (c),
DB[a,l]P (d) or 1-MPA (e). Correlation coefficients (R2) and the line equation are indicated in the graph.
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Table I. Interactive effect on gene expression upon exposure to equitoxic PAH mixtures
Genbank
accession











L19871 ATF3 Activating transcription factor 3 5 5
XM_005207 CA3 Carbonic anhydrase III, muscle specific 5 5 5
L08599 CDH1 Cadherin 1, type 1, E-cadherin (epithelial) 5 5
M18728 CEACAM6 Carcinoembryonic antigen-related cell adhesion
molecule 6 (non-specific cross reacting antigen)
5 5
K03191 CYP1A1 Cytochrome P450, family 1, subfamily A,
polypeptide 1
5 5 5
NM_004104 FASN Fatty acid synthase 5 5
X51473 FGG Fibrinogen, gamma polypeptide 5 5
L37080 FMO5 Flavin-containing monooxygenase 5 5 5
M37484 IGF1 Insulin-like growth factor 1 (somatomedin C) 5 5 5 5 5
M31145 IGFBP1 Insulin-like growth factor-binding protein 1 5 5 5 5
08246 MCL1 Myeloid cell leukemia sequence 1 (BCL2-related) 5 5 5
M55580 SAT Spermidine/spermine N1-acetyltransferase 5 5 5 5 5
AB032261 SCD Stearoyl-CoA desaturase (delta-9-desaturase) 5 5
NM_003332 TYROBP TYRO protein tyrosine kinase-binding protein 5 5 5
XM_005563 5 5 5 5 5
Mostly synergism
J05474 AKR1B1 Aldo-keto reductase family 1, member B1
(aldose reductase)
5 þ þ
XM_003872 AMACR Alpha-methylacyl-CoA racemase þ 5 þ
NM_000761 CYP1A2 Cytochrome P450, family 1, subfamily A,
polypeptide 2
5 þ þ
M10617 FABP1 Fatty acid-binding protein 1, liver þ 5 5 þ
M60974 GADD45A Growth arrest and DNA-damage-inducible, alpha þ þ 5
X97260 MT1E Metallothionein 1E (functional) þ 5 5 þ
M36089 XRCC1 X-ray repair complementing defective repair
in Chinese hamster cells 1
þ þ
Mostly antagonism
X03120 APOC3 Apolipoprotein C-III 5   5 
D49471 ECE1 Endothelin-converting enzyme 1 5    5
XM_004994 GCK Glucokinase (hexokinase 4, maturity onset
diabetes of the young 2)
5    
U22431 HIF1A Hypoxia-inducible factor 1, alpha subunit
(basic helix-loop-helix transcription factor)
 5   5
K01500 SERPINA3 Serine (or cysteine) proteinase inhibitor, clade
A (alpha-1 antiproteinase, antitrypsin), member 3
  5 5 
J04765 SPP1 Secreted phosphoprotein 1 (osteopontin,
bone sialoprotein I, early T-lymphocyte
activation 1)
   
Other interactions
M11313 A2M Alpha-2-macroglobulin  5 5 5
J05474 AKR1B1 Aldo-keto reductase family 1, member B1
(aldose reductase)
5
L22473 BAX BCL2-associated X protein þ
U03106 CDKN1A Cyclin-dependent kinase inhibitor 1A (p21, Cip1) þ 5 5
M17303 CEACAM5 Carcinoembryonic antigen-related cell
adhesion molecule 5
þ 5
AB017493 COPEB Core promoter element-binding protein þ
M13699 CP Ceruloplasmin (ferroxidase) 5
M29874 CYP2B6 Cytochrome P450, family 2, subfamily B,
polypeptide 6
þ
M58569 FGA Fibrinogen, A alpha polypeptide 5 5
M64082 FMO1 Flavin-containing monooxygenase 1
X03674 G6PD Glucose-6-phosphate dehydrogenase 5 5 5  5
XM_004453 HIST1H2AL Histone 1, H2al 5
XM_004419 HIST1H3D Histone 1, H3d 5
M11058 HMGCR 3-hydroxy-3-methylglutaryl-coenzyme A reductase 5 5
X15183 HSPCA Heat shock 90 kDa protein 1, alpha 5
M29645 IGF2 Insulin-like growth factor 2 (somatomedin A) 5 
M13577 MBP Myelin basic protein
U33199 MDM2 Mdm2, transformed 3T3 cell double minute 2,
p53-binding protein (mouse)
5
X92720 PCK2 Phosphoenolpyruvate carboxykinase 2 (mitochondrial) 5
J04718 PCNA Proliferating cell nuclear antigen þ
J04605 PEPD Peptidase D 5
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Synergism or antagonism?
To our knowledge, no previous studies have been done on the inter-
active effects of mixtures on gene expression level. Therefore, we
attempted to develop a method for assessing these effects. Although
we realize this method may not be perfect, we have tried to design
a method which allows studying effects of mixtures on gene expres-
sion level.
To assess the effects of PAH mixtures, an addition of concentrations
is not always accurate (24), since a common mode of action is as-
sumed. Alternatively, a model that assumes no common mode of
action was found to predict the effects of the mixture more accurately.
Our method adds effects on gene expression, and no common mode
of action is required and therefore our method might be a good esti-
mation of the effects of a mixture. However, further development is
required, but our method could be useful for other researchers inter-
ested in interactive effects on gene expression level.
A comparison of interactive effects (Table II) shows that no con-
sistent effects are observed for each mixture. Most previous studies
suggest an additive effect or an antagonistic effect of PAH mixtures
(4,25). This agrees with the effects we found on gene expression,
which were also additive or antagonistic. Interactions of B[b]F, FA
and DB[a,h]A with B[a]P on gene expression are mostly additive. On
DNA adduct formation, the effects are all synergistic, however, and
thus do not agree with the antagonistic or additive effects on gene
expression or other parameters. We have no ready explanation for this
difference. It might be related to the synergistic effect of PAH mix-
tures (B[a]P/DB[a,l]P and B[a]P/DB[a,h]A) on the expression of
CYP1A2, which might result in increased formation of carcinogenic
metabolites and thereby increased DNA adduct formation. The syn-
ergism we found for DNA adduct formation was not found by Gray
et al. (26) for mixtures of B[a]P and 7H-dibenzo[c,g]carbazole on
tumor formation in mice. This might be due to the different com-
pounds tested or the difference of in vivo versus in vitro. However,
James et al. (27) did find a synergism in toxicity of PAHs and Poly-
chlorinated Biphenyls, which are also metabolized by the same en-
zymes of the cytochrome P450 family.
Although 1-MPA and FA did show some effect on the parameters
tested individually, in mixtures both compounds showed to contribute
to the effect of the mixture. This shows that compounds having little
effect by itself, may contribute importantly to the effects of a mixture.
Furthermore, whereas the effects of B[a]P/DB[a,l]P and B[a]P/1-
MPA on gene expression can be antagonistic, the effects on other
parameters can show synergism. Uno et al. (2) found that levels of
DNA adducts were higher in CYP1A1 knockout mice. So, by its
antagonistic effect on gene expression (including CYP1A1), of both
mixtures, the levels of DNA adducts may be increasing, which is in
accordance with what we found.
Conclusion
In our study, we showed that many PAH mixtures show mostly addi-














M12530 TF Transferrin 5 þ
X79929 TNFSF4 Tumor necrosis factor (ligand) superfamily, member 4
(tax-transcriptionally activated glycoprotein 1, 34 kDa)

M76125 UBE2A Ubiquitin-conjugating enzyme E2A (RAD6 homolog) 5 þ
NM_030938 VMP1 Likely ortholog of rat vacuole membrane protein 1 5
Additivity is shown by ‘5’, synergism by ‘þ’ and antagonism by ‘’.
In order to judge the type of interactions on gene expression, the effects caused by the two PAHs is added (expected change) and compared with the expression of
that gene in response to mixture treatment (observed change). Similar expression results in additive response, a higher than expected change results in a synergistic
response and a lower than expected change in an antagonistic response. See Materials and methods for a detailed explanation.
Table II. Summary of data comparison between observed and expected data for the equitoxic experiment
Apoptosis Cell cycle DNA adduct formation Gene expression CYP1A1 expression
B[a]P/B[b]F Additive Unclear Synergism Additive Additive
B[a]P/FA Additive/synergism Unclear Synergism Additive Unclear
B[a]P/DB[a,h]A Additive Unclear Synergism Additive Additive
B[a]P/DB[a,l]P Additive/synergism Unclear Synergism Antagonism Unclear
B[a]P/1-MPA Additive Unclear Synergism Antagonism Additive
Additive effects have no difference between observed and expected data, for synergism the observed effect is higher than expected and for antagonism the observed
effect is lower than expected.
Fig. 7. Ratio between observed and expected gene expression changes for
CYP1A1, GADD45A, APOC3 and HIF1A upon exposure to PAH mixtures
based on microarray data and RT-PCR data.
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cell cycle. For individual genes, the expression of a few genes showed
additivity, but many genes showed interactive effects. The only con-
sistent interactive effect was on DNA adduct formation, which was
always synergistic. Also, compounds like FA and 1-MPA, which do
not induce adducts and are weak or not carcinogenic, have an impact
on the effects of mixtures and thus affect the carcinogenic potency of
PAH mixtures. The synergistic effects of PAH mixtures on DNA
adduct formation suggest a higher carcinogenic potency of PAHs than
based on the individual compounds. However, as the effects on gene
expression are in opposite direction, it cannot be firmly stated whether
PAH mixtures have increased or decreased carcinogenic potencies.
Supplementary material
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